Woodley Farra Manion Portfolio Management Inc. Has $36.35 Million Stake in Johnson & Johnson (NYSE:JNJ)

Key Points

• Woodley Farra Manion Portfolio Management Inc. increased its stake in Johnson & Johnson by 2.3%, holding 219,158 shares valued at approximately $36.35 million, making it the firm's 26th largest holding.
• Johnson & Johnson recently reported quarterly earnings of $2.77 per share, exceeding analysts' expectations of $2.68, with revenue of $23.74 billion, up 5.8% year-over-year.
• The company declared a quarterly dividend of $1.30 per share, corresponding to an annualized dividend of $5.20, representing a yield of 3.09% with a payout ratio of 55.61%.

Woodley Farra Manion Portfolio Management Inc. lifted its position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 2.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 219,158 shares of the company's stock after acquiring an additional 4,949 shares during the quarter. Johnson & Johnson accounts for about 1.8% of Woodley Farra Manion Portfolio Management Inc.'s holdings, making the stock its 26th biggest position. Woodley Farra Manion Portfolio Management Inc.'s holdings in Johnson & Johnson were worth $36,345,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Lantz Financial LLC lifted its holdings in Johnson & Johnson by 3.3% in the first quarter. Lantz Financial LLC now owns 11,974 shares of the company's stock worth $1,986,000 after acquiring an additional 377 shares during the last quarter. Sulzberger Capital Advisors Inc. acquired a new position in shares of Johnson & Johnson during the fourth quarter valued at approximately $453,000. Joel Isaacson & Co. LLC increased its stake in shares of Johnson & Johnson by 3.5% during the first quarter. Joel Isaacson & Co. LLC now owns 74,132 shares of the company's stock valued at $12,294,000 after acquiring an additional 2,526 shares during the period. State of Wyoming grew its position in Johnson & Johnson by 205,580.0% in the fourth quarter. State of Wyoming now owns 10,284 shares of the company's stock worth $1,487,000 after buying an additional 10,279 shares during the last quarter. Finally, Range Financial Group LLC grew its position in Johnson & Johnson by 18.9% during the 1st quarter. Range Financial Group LLC now owns 15,886 shares of the company's stock worth $2,635,000 after purchasing an additional 2,529 shares in the last quarter. Hedge funds and other institutional investors own 69.55% of the company's stock.

Johnson & Johnson Stock Performance

JNJ stock traded up $2.59 during trading hours on Friday, reaching $167.33. The stock had a trading volume of 8,914,735 shares, compared to its average volume of 9,077,193. The stock has a market capitalization of $402.99 billion, a PE ratio of 17.90, a price-to-earnings-growth ratio of 2.13 and a beta of 0.41. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.01 and a quick ratio of 0.76. The stock has a 50-day simple moving average of $157.18 and a 200 day simple moving average of $156.44. Johnson & Johnson has a fifty-two week low of $140.68 and a fifty-two week high of $169.99.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last posted its earnings results on Wednesday, July 16th. The company reported $2.77 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.68 by $0.09. Johnson & Johnson had a net margin of 25.00% and a return on equity of 32.49%. The company had revenue of $23.74 billion during the quarter, compared to analysts' expectations of $22.85 billion. During the same quarter last year, the company posted $2.82 EPS. Johnson & Johnson's quarterly revenue was up 5.8% compared to the same quarter last year. Analysts predict that Johnson & Johnson will post 10.58 EPS for the current fiscal year.

Johnson & Johnson Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Investors of record on Tuesday, August 26th will be given a dividend of $1.30 per share. The ex-dividend date is Tuesday, August 26th. This represents a $5.20 annualized dividend and a yield of 3.1%. Johnson & Johnson's dividend payout ratio (DPR) is currently 55.61%.

Analysts Set New Price Targets

JNJ has been the subject of several analyst reports. Wall Street Zen lowered shares of Johnson & Johnson from a "strong-buy" rating to a "buy" rating in a research note on Friday, July 18th. Leerink Partners cut shares of Johnson & Johnson from an "outperform" rating to a "market perform" rating and lowered their target price for the company from $169.00 to $153.00 in a research note on Tuesday, May 13th. Raymond James Financial reduced their price target on shares of Johnson & Johnson from $165.00 to $162.00 and set an "outperform" rating on the stock in a research report on Monday, April 14th. Benchmark upgraded shares of Johnson & Johnson to a "strong-buy" rating in a research report on Thursday, April 24th. Finally, UBS Group increased their price objective on shares of Johnson & Johnson from $180.00 to $190.00 and gave the company a "buy" rating in a report on Thursday, July 17th. Nine analysts have rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $174.50.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.